An important goal of the GOLD initiative is to counter the nihilistic attitude and to promote a
proactive engagement of physicians and allied healthcare professionals with COPD patients …

The implementation of potential new step‐up or step‐down treatment recommendations in
response to current guidelines is one of the main challenges currently faced in actual daily …

In this guideline update, we highlight important and new findings related to pharmacological
therapy of chronic obstructive pulmonary disease (COPD) that should change clinical …

Methods The ACCESS study (Assessment of Comorbidities in COPD in European
Symptomatic Subjects; NCT01516528; 115058 study) was a prospective, longitudinal …

Chronic obstructive pulmonary disease (COPD) is characterised by progressive airflow
limitation in the presence of identifiable risk factors. Inflammation is the central pathological …

Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of mortality in our
environment and was usually considered to be confined to the lung territory. The latest …

Chronic obstructive pulmonary disease (COPD) is a difficult disease to manage, but recent
research focusing on its pathophysiology has provided direction for the development of new …

Chronic obstructive pulmonary disease (COPD) is a highly prevalent yet under-recognized
and sub-optimally managed disease that is associated with substantial morbidity and …

Exacerbations are a frequent event in the evolution of chronic obstructive pulmonary
disease (COPD) patients. Individuals with COPD have a mean of 1–3 episodes per year …

Chronic obstructive pulmonary disease (COPD) is a heterogeneous condition with
considerable pathophysiological and clinical variability across patients [1]. For this reason …